These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 29764038)

  • 1. [Expression and distribution of programmed death receptor 1 and T cell immunoglobulin mucin 3 in breast cancer microenvironment and its relationship with clinicopathological features].
    Shen H; Sheng H; Lu JJ; Feng C; Yao M; Pan H; Xu LS; Shen JF; Zheng Y; Zhou YL
    Zhonghua Yi Xue Za Zhi; 2018 May; 98(17):1352-1357. PubMed ID: 29764038
    [No Abstract]   [Full Text] [Related]  

  • 2. [Up-regulation of TIM-3 on CD4+ tumor infiltrating lymphocytes predicts poor prognosis in human non-small-cell lung cancer].
    Ji P; Chen D; Bian J; Xia R; Song X; Wen W; Zhang X; Zhu Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Jun; 31(6):808-11. PubMed ID: 26062425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blocking Tim-3 or/and PD-1 reverses dysfunction of tumor-infiltrating lymphocytes in HBV-related hepatocellular carcinoma.
    Liu F; Zeng G; Zhou S; He X; Sun N; Zhu X; Hu A
    Bull Cancer; 2018 May; 105(5):493-501. PubMed ID: 29576222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting PD-1 and Tim-3 Pathways to Reverse CD8 T-Cell Exhaustion and Enhance Ex Vivo T-Cell Responses to Autologous Dendritic/Tumor Vaccines.
    Liu J; Zhang S; Hu Y; Yang Z; Li J; Liu X; Deng L; Wang Y; Zhang X; Jiang T; Lu X
    J Immunother; 2016 May; 39(4):171-80. PubMed ID: 27070448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-Cell Immunoglobulin Mucin 3 Expression on Tumor Infiltrating Lymphocytes as a Positive Prognosticator in Triple-Negative Breast Cancer.
    Byun KD; Hwang HJ; Park KJ; Kim MC; Cho SH; Ju MH; Lee JH; Jeong JS
    J Breast Cancer; 2018 Dec; 21(4):406-414. PubMed ID: 30607162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of TIM-3 expression and its prognostic value in patients with surgically resected lung adenocarcinoma.
    Su H; Xie H; Dai C; Ren Y; She Y; Xu L; Chen D; Xie D; Zhang L; Jiang G; Chen C
    Lung Cancer; 2018 Jul; 121():18-24. PubMed ID: 29858021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell immunoglobulin and mucin-domain containing-3 in non-small cell lung cancer.
    Jia K; He Y; Dziadziuszko R; Zhao S; Zhang X; Deng J; Wang H; Hirsch FR; Zhou C; Yu H; Zhang L
    Transl Lung Cancer Res; 2019 Dec; 8(6):895-906. PubMed ID: 32010568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased exhausted CD8
    Tan J; Chen S; Huang J; Chen Y; Yang L; Wang C; Zhong J; Lu Y; Wang L; Zhu K; Li Y
    Asia Pac J Clin Oncol; 2018 Oct; 14(5):e266-e274. PubMed ID: 29943497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High co-expression of immune checkpoint receptors PD-1, CTLA-4, LAG-3, TIM-3, and TIGIT on tumor-infiltrating lymphocytes in early-stage breast cancer.
    Mollavelioglu B; Cetin Aktas E; Cabioglu N; Abbasov A; Onder S; Emiroglu S; Tükenmez M; Muslumanoglu M; Igci A; Deniz G; Ozmen V
    World J Surg Oncol; 2022 Oct; 20(1):349. PubMed ID: 36271406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell Counts, rather than Proportion, of CD8/PD-1 Tumor-Infiltrating Lymphocytes in a Tumor Microenvironment Associated with Pathological Characteristics of Chinese Invasive Ductal Breast Cancer.
    Song Q; Shi F; Adair M; Chang H; Guan X; Zhao Y; Li Y; Wu G; Wu J
    J Immunol Res; 2019; 2019():8505021. PubMed ID: 31049361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of Curcumin on multi-level immune checkpoint blockade and T cell dysfunction in head and neck cancer.
    Liu L; Lim MA; Jung SN; Oh C; Won HR; Jin YL; Piao Y; Kim HJ; Chang JW; Koo BS
    Phytomedicine; 2021 Nov; 92():153758. PubMed ID: 34592487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TIM-3 expression characterizes regulatory T cells in tumor tissues and is associated with lung cancer progression.
    Gao X; Zhu Y; Li G; Huang H; Zhang G; Wang F; Sun J; Yang Q; Zhang X; Lu B
    PLoS One; 2012; 7(2):e30676. PubMed ID: 22363469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-expression of PD-1 with TIGIT or PD-1 with TIM-3 on tumor-infiltrating CD8
    Meyiah A; Mahmoodi Chalbatani G; Al-Mterin MA; Malekraeisi MA; Murshed K; Elkord E
    Int Immunopharmacol; 2023 Jun; 119():110207. PubMed ID: 37099940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PD-L1 expression of the residual tumor serves as a prognostic marker in local advanced breast cancer after neoadjuvant chemotherapy.
    Chen S; Wang RX; Liu Y; Yang WT; Shao ZM
    Int J Cancer; 2017 Mar; 140(6):1384-1395. PubMed ID: 27925176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell immunoglobulin mucin-3 expression in invasive ductal breast carcinoma: Clinicopathological correlations and association with tumor infiltration by cytotoxic lymphocytes.
    Zhang H; Xiang R; Wu B; Li J; Luo G
    Mol Clin Oncol; 2017 Oct; 7(4):557-563. PubMed ID: 28855989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PD-1+ TIM-3+ T cells in malignant ascites predict prognosis of gastrointestinal cancer.
    Nakano M; Ito M; Tanaka R; Yamaguchi K; Ariyama H; Mitsugi K; Yoshihiro T; Ohmura H; Tsuruta N; Hanamura F; Sagara K; Okumura Y; Nio K; Tsuchihashi K; Arita S; Kusaba H; Akashi K; Baba E
    Cancer Sci; 2018 Sep; 109(9):2986-2992. PubMed ID: 30187676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spatially resolved analysis of the T cell immune contexture in lung cancer-associated brain metastases.
    Lu BY; Gupta R; Aguirre-Ducler A; Gianino N; Wyatt H; Ribeiro M; Chiang VL; Contessa JN; Adeniran AJ; Jilaveanu LB; Kluger HM; Schalper KA; Goldberg SB
    J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34670827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating and tumor-infiltrating Tim-3 in patients with colorectal cancer.
    Xu B; Yuan L; Gao Q; Yuan P; Zhao P; Yuan H; Fan H; Li T; Qin P; Han L; Fang W; Suo Z
    Oncotarget; 2015 Aug; 6(24):20592-603. PubMed ID: 26008981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity.
    Sakuishi K; Apetoh L; Sullivan JM; Blazar BR; Kuchroo VK; Anderson AC
    J Exp Med; 2010 Sep; 207(10):2187-94. PubMed ID: 20819927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Implications of Tumor-Infiltrating Lymphocytes in Association With Programmed Death Ligand 1 Expression in Early-Stage Breast Cancer.
    Park IH; Kong SY; Ro JY; Kwon Y; Kang JH; Mo HJ; Jung SY; Lee S; Lee KS; Kang HS; Lee E; Joo J; Ro J
    Clin Breast Cancer; 2016 Feb; 16(1):51-8. PubMed ID: 26364145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.